1. Influence of magnetic nanoparticle biotransformation on contrasting efficiency and iron metabolism
- Author
-
Alexey V. Yaremenko, Ivan V. Zelepukin, Ilya N. Ivanov, Roman O. Melikov, Nadezhda A. Pechnikova, Dzhuliia Sh. Dzhalilova, Aziz B. Mirkasymov, Vera A. Bragina, Maxim P. Nikitin, Sergey M. Deyev, and Petr I. Nikitin
- Subjects
Biomedical Engineering ,Pharmaceutical Science ,Molecular Medicine ,Medicine (miscellaneous) ,Bioengineering ,Applied Microbiology and Biotechnology - Abstract
Magnetic nanoparticles are widely used in biomedicine for MRI imaging and anemia treatment. The aging of these nanomaterials in vivo may lead to gradual diminishing of their contrast properties and inducing toxicity. Here we describe observation of the full lifecycle of 50-nm magnetic particles from their injection to the complete degradation in vivo and associated impact on the organism. We found that in 2 hours nanoparticles were eliminated from the bloodstream, but their initial biodistribution changed over time. In 1 week major part of nanoparticles was transferred to the liver and spleen, where they degraded with a half-life of 21 days. MRI and magnetic spectral approach revealed preservation of contrast in these organs for more than 1 month. Particle degradation led to increased number of red blood cells and blood hemoglobin level due to released iron without causing any toxicity in tissues. Also, we observed an increase in gene expression level of Fe-associated proteins such as transferrin, DMT1 and ferroportin in the liver in response to iron particle degradation. A deeper understanding of the organism response to the particle degradation can bring new directions to the field of MRI contrast agent design.
- Published
- 2022